After systemic IL-17A blockade, the expression of KRT15 was increased in posttreatment psoriasis lesional skin KCs compared to pretreatment psoriasis lesional skin KCs (Figure 6A, p < 0.05). The gene discussed is IL17A; the disease is psoriasis.